Demant to sell Oticon Medical to Impilo

Case News
Demant, a world-leading hearing healthcare group headquartered in Denmark and listed on Nasdaq Copenhagen, has signed an agreement to divest Oticon Medical to Impilo. Plesner advised Demant A/S in connection with the divestment.

Oticon Medical is a global company dedicated to bringing the power of sound to people at every stage of life with bone anchored hearing solutions. 

Impilo is a Nordic investment company focused on investments in Nordic healthcare companies.

As part of the agreement Demant will support Impilo for a defined period of time, as they develop Oticon Medical into a stand-alone business. These transitional services will include inter alia the joint development of next-generation products and the supply of existing and future sound processors.

The transaction is subject to customary closing conditions and regulatory approvals.

Plesner's core M&A team on the transaction consisted of Thomas Holst Laursen, Simon Västernäs, Louise Lund, Kirstine Juel Månsson and Kasper Nørgaard Carlsen.

Read Demant A/S' press release